Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
DRPLA - Dentatorubral-Pallidoluysian Atrophy Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Atrophin 1 (ATN1) gene CAG triplet repeat test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
ATN1 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
ATN1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 16 loci) Variantyx, Inc. United States | 15 | 13 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
Dentatorubral-Pallidoluysian Atrophy (DRPLA) via the ATN1 CAG Repeat Expansion PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 13 | 13 |
|
Dentatorubral-pallidoluysian atrophy (DRPLA, CAG repeat expansion on ATN1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Genetic Test for Dentatorubral-pallidoluysian atrophy - DRPLA CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology Portugal | 1 | 1 |
|
Genetic Test for Spinocerebellar Ataxias - SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 and DRPLA CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology Portugal | 7 | 7 |
|
Dentatorubral-pallidoluysian atrophy: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
DRPLA (ATN1) Genetic Testing (Repeat expansion) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 1 | 1 |
|
Spinocerebellar Ataxia Repeat Panel (SCA 8, 10, 12, 17, 36, & DRPLA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 6 | 6 |
|
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 12 | 12 |
|
Ataxia Repeat Expansion Analysis Fulgent Genetics United States | 19 | 15 |
|
ATN1 (Dentatorubral-Pallidoluysian Atrophy) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.